Erythropoietin activates Phosphoinositide-3-kinase (PI3K)

Stable Identifier
R-HSA-9027276
Type
Pathway
Species
Homo sapiens
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this pathway in the Pathway Browser
PI3K can bind the activated EPO receptor (EPOR) by three different mechanisms: direct binding to phospho-Y479 of the EPOR, indirect binding via phosphorylated IRS2 bound to the EPOR, and indirect binding via phosphorylated GAB1 bound to the EPOR (Bouscary et al. 2003, Schmidt et al. 2004, reviewed in Kuhrt and Wojchowski 2015). PI3K phosphorylates phosphatidylinositol 4,5-bisphosphate to yield phosphatidylinositol 3,4,5-trisphosphate which recruits AKT1 to the membrane.
Literature References
PubMed ID Title Journal Year
25887776 Emerging EPO and EPO receptor regulators and signal transducers

Wojchowski, DM, Kuhrt, D

Blood 2015
12506011 Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation

Claessens, YE, Mayeux, P, Fontenay-Roupie, M, Bouscary, D, Pene, F, Lacombe, C, Muller, O, Chrétien, S, Gisselbrecht, S

Blood 2003
15149544 PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors

Schmidt, EK, Feller, SM, Fichelson, S

BMC Biol. 2004
Participants
Participates
Event Information
Orthologous Events
Cross References
BioModels Database
Authored
Reviewed
Created
Cite Us!